Colorectal Carcinoma
|
0.300 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Red Blood Cell Count measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Finding of Mean Corpuscular Hemoglobin
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Glaucoma, Open-Angle
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Analysis combining correlated glaucoma traits identifies five new risk loci for open-angle glaucoma.
|
29449654 |
2018 |
Tonometry
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association study of intraocular pressure uncovers new pathways to glaucoma.
|
30054594 |
2018 |
Tonometry
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide analyses identify 68 new loci associated with intraocular pressure and improve risk prediction for primary open-angle glaucoma.
|
29785010 |
2018 |
Tonometry
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association analyses identify new loci influencing intraocular pressure.
|
29617998 |
2018 |
Bipolar Disorder
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association studies of smooth pursuit and antisaccade eye movements in psychotic disorders: findings from the B-SNIP study.
|
29064472 |
2017 |
Schizoaffective Disorder
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association studies of smooth pursuit and antisaccade eye movements in psychotic disorders: findings from the B-SNIP study.
|
29064472 |
2017 |
Schizophrenia
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association studies of smooth pursuit and antisaccade eye movements in psychotic disorders: findings from the B-SNIP study.
|
29064472 |
2017 |
Diabetic Retinopathy
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association study in a Chinese population with diabetic retinopathy.
|
23562823 |
2013 |
Diabetes Mellitus, Insulin-Dependent
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
A genome-wide meta-analysis of six type 1 diabetes cohorts identifies multiple associated loci.
|
21980299 |
2011 |
Diabetes Mellitus, Insulin-Dependent
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
A genome-wide meta-analysis of six type 1 diabetes cohorts identifies multiple associated loci.
|
21980299 |
2011 |
Neoplasms
|
0.030 |
Biomarker
|
group |
BEFREE |
The present study indicated that LRIG2 and LMO7 may be useful prognostic markers in VSCC, particularly for patients without HPV‑driven tumors or with advanced tumors at diagnosis.
|
31059071 |
2019 |
Neoplasms
|
0.030 |
GeneticVariation
|
group |
BEFREE |
The LMO7-BRAF fusion was a recurrent somatic alteration with a frequency of 2.0% (3/148) in PTC tumors, while the BRAF<sup>V600E</sup> point mutation was found in 63.5% (94/148) of tumors.
|
29768105 |
2018 |
Neoplasms
|
0.030 |
Biomarker
|
group |
BEFREE |
LMO7 immunoreactivity was shown to be a negative prognostic factor in LRIG1 positive tumors, predicting poor patient survival.
|
30429017 |
2018 |
Muscular Dystrophy, Emery-Dreifuss
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
LMO7 (LIM domain only 7) is a transcription regulator for expression of many Emery-Dreifuss muscular dystrophy-relevant genes, and binds to α-actinin and AF6/afadin at adherens junctions for epithelial cell-cell adhesion.
|
29158164 |
2018 |
Muscular Dystrophy, Emery-Dreifuss
|
0.030 |
Biomarker
|
disease |
BEFREE |
To test this, we analyzed RNA-Seq datasets, finding novel isoforms or isoform tissue-specificity for: Lap2, linked to cardiomyopathy; Nesprin 2, linked to Emery-Dreifuss muscular dystrophy and Lmo7, that regulates the Emery-Dreifuss muscular dystrophy linked emerin gene.
|
29912636 |
2018 |
Muscular Dystrophy, Emery-Dreifuss
|
0.030 |
Biomarker
|
disease |
BEFREE |
These findings demonstrate that loss of Lmo7 in mice causes myopathic phenotypes similar to those seen in other EDMD mouse models.
|
24825363 |
2015 |
Malignant neoplasm of lung
|
0.020 |
Biomarker
|
disease |
BEFREE |
LMO7 and LIMCH1 interact with LRIG proteins in lung cancer, with prognostic implications for early-stage disease.
|
30429017 |
2018 |
Carcinoma of lung
|
0.020 |
Biomarker
|
disease |
BEFREE |
LMO7 and LIMCH1 interact with LRIG proteins in lung cancer, with prognostic implications for early-stage disease.
|
30429017 |
2018 |
Primary malignant neoplasm of lung
|
0.020 |
Biomarker
|
disease |
BEFREE |
LMO7 and LIMCH1 interact with LRIG proteins in lung cancer, with prognostic implications for early-stage disease.
|
30429017 |
2018 |
Malignant neoplasm of lung
|
0.020 |
Biomarker
|
disease |
BEFREE |
The miR-96-LMO7 axis may be a therapeutic target for lung cancer patients, and new diagnostic or therapeutic strategies could be developed by targeting the miR-96-LMO7 axis.
|
28026121 |
2017 |
Carcinoma of lung
|
0.020 |
Biomarker
|
disease |
BEFREE |
The miR-96-LMO7 axis may be a therapeutic target for lung cancer patients, and new diagnostic or therapeutic strategies could be developed by targeting the miR-96-LMO7 axis.
|
28026121 |
2017 |